ProNAi Therapeutics
ProNAi Therapeutics
A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.
About
What does ProNAi Therapeutics do?
ProNAi Therapeutics is a clinical-stage oncology company focused on developing and commercializing novel cancer therapies. Their proprietary DNA interference (DNAi) technology platform targets specific genes within cancer cells to inhibit proliferation and induce cell death. Their lead candidate, PN
What is ProNAi Therapeutics's revenue?
StartupHub estimates ProNAi Therapeutics's annual revenue at $8.5M (range $3.9M to $114.2M, 30% confidence), based on comparable companies in the sector.
What is ProNAi Therapeutics's valuation?
StartupHub estimates ProNAi Therapeutics's effective valuation at $446.1M (range $289.4M to $694.5M, 10% confidence), based on comparable companies in the sector.
How much funding has ProNAi Therapeutics raised?
ProNAi Therapeutics has raised a total of $116M in funding. The most recent round on record is Series D.
When was ProNAi Therapeutics founded?
ProNAi Therapeutics was founded in 2004.
What industry does ProNAi Therapeutics operate in?
ProNAi Therapeutics operates in Biotech, Drug Discovery, Clinical Trials, Oncology, Phage Therapy, DNAi Technology.
What is ProNAi Therapeutics's current status?
ProNAi Therapeutics's current operating status is: Inactive.
“Biotech stock plunges 68%... how to invest without the risk?. Read this http://www.breakingreportnews.com/pronai-therapeutics-shows-how-investing-in-biotech-ipos-is-a-game-of-chance/ Scary thing is that I was researching this company heavil…”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.